Mansueto Cashes Out: Morningstar Executive Chairman Sells 22K Shares
November 22, 2023
☀️Trending News
Mansueto, the executive chairman of Morningstar ($NASDAQ:MORN), has recently sold 22,000 shares of the company. This news has come as a surprise to many investors, as Morningstar is a widely successful financial services company that is traded on the Nasdaq. Morningstar’s stock has seen significant value growth over the last few years, making Mansueto’s sale of shares an interesting move. The ultimate impact of Mansueto’s sale remains to be seen.
While the 22,000 shares only make up a small portion of his total holdings, it is nonetheless an unexpected move that has many investors watching closely. It is possible that this could be a signal of potential changes within Morningstar, or simply a decision to diversify his portfolio. Only time will tell how this news will affect the company in the long run.
Market Price
On Tuesday, MORNINGSTAR experienced a small uptick in its stock price, with its opening price at $272.6 and its closing price at $274.9, representing a 0.9% increase from its prior closing price of $272.4. This small increase was likely overshadowed by the news that the company’s Executive Chairman, Joe Mansueto, had sold off 22,000 shares of Morningstar stock. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Morningstar. More…
| Total Revenues | Net Income | Net Margin |
| 1.97k | 70.9 | 3.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Morningstar. More…
| Operations | Investing | Financing |
| 282.1 | -87.4 | -251.7 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Morningstar. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 3.34k | 2.1k | 28.97 |
Key Ratios Snapshot
Some of the financial key ratios for Morningstar are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 13.8% | -3.3% | 8.8% |
| FCF Margin | ROE | ROA |
| 7.9% | 8.8% | 3.3% |
Analysis
At GoodWhale, we analyze the financials of MORNINGSTAR to come up with a comprehensive report. From our Star Chart, MORNINGSTAR is strong in dividend and profitability, and medium in growth. Its weakest point is asset. According to our health score, MORNINGSTAR has a high score of 8/10, which suggests it is ready to weather any crisis period. Furthermore, on the basis of our analysis, we classify MORNINGSTAR as ‘rhino’, a type of company that has achieved moderate revenue or earnings growth. Therefore, this company may be of interest to investors who are looking for companies with a good dividend yield and sizeable growth potential. Additionally, it may also appeal to investors focusing on long-term value. More…
Peers
The competition between Morningstar Inc and its competitors is fierce. Euromoney Institutional Investor PLC, MSCI Inc, and CRISIL Ltd are all major players in the financial research and analysis industry, and each company is constantly innovating and trying to one-up the others. Morningstar Inc has been a leader in the industry for many years, but its competitors are quickly catching up.
– Euromoney Institutional Investor PLC ($LSE:ERM)
Euromoney Institutional Investor PLC is a provider of business information and research for the global financial markets. The company has a market capitalization of 1.59 billion as of 2022 and a return on equity of 2.93%. The company’s products and services include news, analysis, and research on the global financial markets, as well as data and intelligence on companies, industries, and economies.
– MSCI Inc ($NYSE:MSCI)
MSCI Inc is a global investment management company that provides indexes and analytics for use in investment decisions. As of 2022, the company had a market capitalization of $39.2 billion and a return on equity of -70.72%. The company’s products are used by investment professionals, including asset managers, banks, and insurance companies, to make investment decisions.
– CRISIL Ltd ($BSE:500092)
CRISIL Ltd is a global analytical company providing ratings, research, and risk and policy advisory services. The company’s market cap as of 2022 is 218.36B, and its ROE is 30.52%. CRISIL’s products and services cover a wide range of industries and sectors, including banking, finance, and investment; infrastructure; power; and telecommunications. The company has a strong presence in India and also operates in the United States, Europe, and Asia.
Summary
Morningstar is a leader in investment analysis. Recently, executive chairman Joseph Mansueto sold 22,000 shares of the company’s stock. Traders are taking this as a sign that the company’s current fundamentals may not be as strong as previously thought and that the stock may be overvalued.
However, this sale does not appear to have affected the company’s long-term outlook, as Morningstar has continued to outperform its competitors in the investment analysis space. As such, investors may want to consider Morningstar as a long-term investment despite the recent dip in stock prices.
Related Posts
Recent Posts
